AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Immune Response Corp. wins patent for T-cell receptor peptide vaccine.(Brief Article)

Vaccine Weekly

| August 28, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 AUG 28 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNR) announced it was recently granted United States Patent No. 6,413,516 entitled "Peptides and Methods Against Psoriasis." The new patent includes composition and methods claims.

The vaccine may suppress the activity of specific T-cells that are thought to play a role in the development of psoriasis.

"This U.S. patent for our psoriasis TCR peptide vaccine strengthens our worldwide intellectual property position in therapeutic vaccines for autoimmune diseases," said Dr. Dennis J. Carlo, president and chief executive officer of the Immune Response Corp.

"With the addition of this psoriasis patent, we now have coverage in the major world markets for our TCR ...

Related articles from newspapers, magazines, journals, and more
Immune response still troubled: Immune Response Corp.(Brief Article)
Magazine article from: San Diego Business Journal April 5, 2004 700+ words
Immune Response Still Troubled: Immune Response Corp. said it has enough cash to last through the third quarter. Meanwhile, the company will try to raise additional financing to run operations past the third quarter, according to an annual...
The Immune Response Corp. (Earnings)
Magazine article from: San Diego Business Journal August 5, 1991 700+ words
The Immune Response Corp. The Immune Response Corp. lost $927,000, or 7 cents a share, on research revenue of $1.1 million for the second quarter ending June 30. That compares to income of $566,000, or 2 cents a share, on research...
SIRNA, IMMUNE RESPONSE PAD COFFERS WITH PRIVATE PLACEMENTS.(Immune Response...
Magazine article from: BIOWORLD Today Lorenzo, Aaron May 5, 2004 700+ words
...Writer Sirna Therapeutics Inc. and The Immune Response Corp. both pulled in funding from private...systemically." Proceeds To Fund Development At Immune Response Carlsbad, Calif.-based Immune Response raised about $12 million after entering...
THE IMMUNE RESPONSE CORP. CONFIRMS SCHEDULE FOR COMPLETION OF PHASE II/III...
Press release article from: PR Newswire March 7, 1992 700+ words
THE IMMUNE RESPONSE CORP. CONFIRMS SCHEDULE FOR COMPLETION...March 7 /PRNewswire/ -- The Immune Response Corp. (NASDAQ-NMS: IMNR) announced...chief executive officer of The Immune Response Corp. An article in the March 6...
THE IMMUNE RESPONSE CORP. ANNOUNCES THIRD QUARTER 1991 FINANCIAL RESULTS
Press release article from: PR Newswire November 6, 1991 700+ words
THE IMMUNE RESPONSE CORP. ANNOUNCES THIRD QUARTER 1991...Nov. 6 /PRNewswire/ -- The Immune Response Corp. (NASDAQ-NMS: IMNR) today...operating results of the company. The Immune Response Corp. is a biopharmaceutical company...
The Immune Response Corp. to Present at Institutional Investors Forum 2004.
Press release article from: Business Wire February 20, 2004 700+ words
...BUSINESS WIRE)--Feb. 20, 2004 The Immune Response Corp. (NASDAQ: IMNR), a biopharmaceutical...s Web site for 30 days. About The Immune Response Corp. and REMUNE(R) The Immune Response Corp. is developing immune-based therapies...
The Immune Response Corp. to Present at Wall Street Analyst Forum 51st NYC...
Press release article from: Business Wire February 24, 2004 700+ words
...BUSINESS WIRE)--Feb. 24, 2004 The Immune Response Corp. (NASDAQ: IMNR), a biopharmaceutical...s Web site for 30 days. About The Immune Response Corp. and REMUNE(R) The Immune Response Corp. is developing immune-based therapies...
Immune Response Adds Cash, Raises $12M For HIV Vaccines.(Immune Response Corp.)
Magazine article from: BIOWORLD Today Lorenzo, Aaron October 15, 2003 700+ words
...Lorenzo, Staff Writer The Immune Response Corp. raised about $12 million...term investments. But Immune Response Corp. has worked to improve that...antiretroviral therapy. Immune Response Corp.'s next-generation HIV...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA